Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Michael, Povey"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide. In the Unit
Externí odkaz:
https://doaj.org/article/fabab714a90042afb694983316b19302
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 10, Pp 3747-3756 (2021)
Varicella-zoster virus (VZV) infections cause a substantial disease burden, which is underestimated due to incomplete reporting data and lack of serological surveillance. In this post-hoc analysis of a randomized, Phase IIIb clinical trial (NCT002264
Externí odkaz:
https://doaj.org/article/e22b0bdf08ce4ab0925762c1ee63294e
Autor:
Leyla Namazova-Baranova, Md Ahsan Habib, Michael Povey, Kamilla Efendieva, Olga Fedorova, Marina Fedoseenko, Tatyana Ivleva, Yulia Kovshirina, Julia Levina, Artem Lyamin, Ludmila Ogorodova, Olga Reshetko, Viktor Romanenko, Inna Ryzhenkova, Irina Sidorenko, Yakov Yakovlev, Aleksandr Zhestkov, Vladimir Tatochenko, Michael Scherbakov, Evgeniy L Shpeer, Giacomo Casabona, on behalf of the OKAH-182 Russia Study Group
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
In Russia, a universal varicella vaccination (UVV) program has not been implemented, and varicella vaccination coverage is low. We assessed the efficacy, antibody persistence, and safety of one- and two-dose varicella vaccination schedules in Russian
Externí odkaz:
https://doaj.org/article/a09a1cbafeec43a69f420ab66223eb04
Autor:
Saul N. Faust, Maguelone Le Roy, Chitsanu Pancharoen, Miguel Angel Rodriguez Weber, Katrina Cathie, Ulrich Behre, Jolanta Bernatoniene, Matthew D. Snape, Klaus Helm, Carlos Eduardo Medina Pech, Ouzama Henry, Carmen Baccarini, Michael Povey, Paul Gillard
Publikováno v:
BMC Pediatrics, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background A new formulation of the live-attenuated varicella vaccine Varilrix (GSK) produced without human serum albumin (HSA) was developed to minimize a theoretical risk of transmission of infectious diseases. A previous study showed that
Externí odkaz:
https://doaj.org/article/19b8f451f93243849ae1c79a7f7b5a2a
Autor:
Remon Abu-Elyazeed, William Jennings, Randall Severance, Michael Noss, Adrian Caplanusi, Michael Povey, Ouzama Henry
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 11, Pp 2624-2631 (2018)
The introduction of vaccination programs against measles, mumps, and rubella (MMR) led to significant global reduction in morbidity and mortality from these diseases. The currently recommended MMR vaccination schedule in the United States of America
Externí odkaz:
https://doaj.org/article/632bc8e2ad7849208d22446948c76815
Autor:
Andrea A. Berry, Remon Abu-Elyazeed, Clemente Diaz-Perez, Maurice A. Mufson, Christopher J. Harrison, Michael Leonardi, Jerry D. Twiggs, Christopher Peltier, Stanley Grogg, Antonio Carbayo, Steven Shapiro, Michael Povey, Carmen Baccarini, Bruce L. Innis, Ouzama Henry
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 7, Pp 1516-1522 (2017)
One combined measles-mumps-rubella (MMR) vaccine without Human Serum Albumin (HSA) is currently licensed in the USA (M-M-R II; Merck, USA) and another has been developed (Priorix™ [MMR-RIT, GSK, Belgium]). In this follow-up study, children from USA
Externí odkaz:
https://doaj.org/article/30e7337c65194fa8bf1cdd36c9885fa9
Autor:
Ketil Arne Espnes, Carl-Erik Flodmark, Camilla Tøndel, Marianne A. Riise Bergsaker, Michael Povey, Giacomo Casabona, Sven Arne Silfverdal, Ahsan Habib
Publikováno v:
Acta Paediatrica. 111:391-400
Aim Several countries, such as Norway and Sweden, have not implemented universal varicella vaccination. We present data for Norway and Sweden that were generated by a paediatric multi-country Phase III study over a 10-year period. This assessed the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185d8ac5d3c313c49f16d0fac24a09d8
https://doi.org/10.1111/apa.16136
https://doi.org/10.1111/apa.16136
Autor:
Rafael Harpaz, Brigitte Cheuvart, Stéphane Carryn, Robbert van der Most, Giacomo Casabona, Alemnew F Dagnew, Michael Povey
Publikováno v:
The Journal of Infectious Diseases
Background Universal varicella vaccination might reduce opportunities for varicella-zoster virus (VZV) exposure and protective immunological boosting, thus increasing herpes zoster incidence in latently infected adults. We assessed humoral and cell-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71e637f9cf8a2a07ddb9085a3b509e8a
https://doi.org/10.1093/infdis/jiab500
https://doi.org/10.1093/infdis/jiab500
Autor:
Michael Povey, Paul Gillard, Vytautas Usonis, Roman Prymula, Jacek Wysocki, Susanna Esposito, Ouzama Henry, Stéphanie Ravault, Ahsan Habib, Stephane Carryn
Publikováno v:
Vaccine, Oxford : Elsevier Ltd, 2021, vol. 39, no. 25, p. 3445-3454
Background: Varicella vaccination confers high and long-lasting protection against chickenpox and induces robust immune responses, but an absolute correlate of protection (CoP) against varicella has not been established. This study models the relatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc239abcd28f21e346d0d42b26edec00
https://doi.org/10.1016/j.vaccine.2021.02.074
https://doi.org/10.1016/j.vaccine.2021.02.074
Autor:
Corinne Willame, Emmanuel Aris, Gillian Hall, Brigitte Cheuvart, Michael Povey, Catherine Cohet
Publikováno v:
Pediatric Infectious Disease Journal. 40:590-596
BACKGROUND Evidence on vaccine effectiveness (VE) may encourage vaccination and help fight the reemergence of measles and mumps in Europe. However, limited data exist on real-life effectiveness of individual measles, mumps and rubella (MMR) vaccines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef16a66a34e23ba861e4b2d4332de958
https://doi.org/10.1097/inf.0000000000003111
https://doi.org/10.1097/inf.0000000000003111